Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.

Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
复制标题

磁共振弹性图以及MEFIB指数和与肝脏相关的结果的肝僵硬在非酒精性脂肪肝病中的结局:对个别参与者的系统评价和荟萃分析。

DOI:
10.1053/j.gastro.2022.06.073
复制
发表时间:
2022-10
期刊:
影响因子:
29.4
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

磁共振弹性成像(MRE)是肝纤维化的准确生物标志物,然而,有限的数据表征其与临床结局的相关性。我们对非酒精性脂肪性肝病(NAFLD)患者进行了个体参与者数据汇总荟萃分析(IPDMA),以评估MRE的肝硬度(LS)与肝脏相关结局之间的相关性。一项系统性检索确定了6个接受基线MRE的NAFLD成人队列,并对肝功能失代偿、肝细胞癌(HCC)和死亡进行了随访。采用考克斯回归和逻辑回归评估LS对MRE和肝脏相关结局之间的相关性,包括定义为需要治疗的静脉曲张、腹水和肝性脑病的复合主要结局。该IPDMA包括2018例患者(53%为女性),平均(±标准差)年龄为57.8(±14)岁,基线MRE分别为4.15(±2.19)kPa。在1707例有可用纵向数据的患者中,中位(IQR)随访时间为3(4.2)年,与MRE < 5 kPa的患者相比,MRE在5-8 kPa之间的主要结局风险比(HR)为11.0(95%CI:7.03-17.1,P <.001),≥ 8 kPa的主要结局风险比(HR)为15.9(95%CI:9.32-27.2,P < .001)。MEFIB指数(当MRE ≥ 3.3kPa且FIB-4 ≥ 1.6时定义为阳性)与主要结局具有强相关性,HR为20.6(95% CI:10.4-40.8,P < .001),MEFIB阴性对主要结局具有较高的阴性预测值,5年时为99.1%。MRE<5 kPa、5-8 kPa和MRE≥8 kPa的3年HCC发生率分别为0.35%、5.25%和5.66%。通过MRE评估的肝硬度与肝脏相关事件相关,并且MRE和FIB-4的组合对肝功能失代偿具有极好的阴性预测值。这些数据对临床实践具有重要意义。
Magnetic resonance elastography (MRE) is an accurate biomarker of liver fibrosis, however, limited data characterize its association with clinical outcomes. We conducted individual participant data pooled meta-analysis (IPDMA) on patients with nonalcoholic fatty liver disease (NAFLD) to evaluate the association between liver stiffness (LS) on MRE and liver-related outcomes. A systematic search identified 6 cohorts of adults with NAFLD who underwent a baseline MRE and were followed for hepatic decompensation, hepatocellular carcinoma (HCC) and death. Cox- and logistic-regression were used to assess the association between LS on MRE and liver-related outcomes including a composite primary outcome defined as varices needing treatment, ascites and hepatic encephalopathy. This IPDMA included 2018 patients (53% women) with a mean (± standard deviation) age of 57.8 (±14) years and MRE at baseline of 4.15 (±2.19) kPa, respectively. Among 1707 patients with available longitudinal data with a median (IQR) of 3 (4.2) years of follow-up, the hazard ratio (HR) for the primary outcome for MRE between 5–8 kPa was 11.0 (95%CI: 7.03–17.1, P < .001) and for ≥ 8 kPa was 15.9 (95%CI:9.32–27.2, P < .001), compared to those with MRE < 5 kPa. The MEFIB index (defined as positive when MRE ≥ 3.3kPa and FIB-4 ≥ 1.6) had a robust association with the primary outcome with a HR of 20.6 (95% CI: 10.4–40.8, P < .001) and a negative MEFIB had a high negative predictive value for the primary outcome, 99.1% at 5 years. The 3-year risk of incident HCC was 0.35% for MRE<5 kPa, 5.25% for 5–8 kPa, and 5.66% for MRE≥8 kPa, respectively. Liver stiffness assessed by MRE is associated with liver-related events and the combination of MRE and FIB-4 has excellent negative predictive value for hepatic decompensation. These data have important implications for clinical practice.
DOI: 10.1056/nejmoa2029349
发表时间: 2021-10-21
期刊: The New England journal of medicine
影响因子: --
作者:
Sanyal AJ;Van Natta ML;Clark J;Neuschwander-Tetri BA;Diehl A;Dasarathy S;Loomba R;Chalasani N;Kowdley K;Hameed B;Wilson LA;Yates KP;Belt P;Lazo M;Kleiner DE;Behling C;Tonascia J;NASH Clinical Research Network (CRN)
通讯作者: NASH Clinical Research Network (CRN)
DOI: 10.1053/j.gastro.2015.04.043
发表时间: 2015-08
期刊: Gastroenterology
影响因子: 29.4
作者:
Angulo P;Kleiner DE;Dam-Larsen S;Adams LA;Bjornsson ES;Charatcharoenwitthaya P;Mills PR;Keach JC;Lafferty HD;Stahler A;Haflidadottir S;Bendtsen F
通讯作者: Bendtsen F
DOI: 10.1111/apt.16745
发表时间: 2022-02
影响因子: 7.6
作者:
Higuchi, Mayu;Tamaki, Nobuharu;Kurosaki, Masayuki;Inada, Kento;Kirino, Sakura;Yamashita, Koji;Hayakawa, Yuka;Osawa, Leona;Takaura, Kenta;Maeyashiki, Chiaki;Kaneko, Shun;Yasui, Yutaka;Takahashi, Yuka;Tsuchiya, Kaoru;Nakanishi, Hiroyuki;Itakura, Jun;Loomba, Rohit;Enomoto, Nobuyuki;Izumi, Namiki
通讯作者: Izumi, Namiki
DOI: 10.1053/j.gastro.2019.12.053
发表时间: 2020-05
期刊: Gastroenterology
影响因子: 29.4
作者:
Loomba R;Lim JK;Patton H;El-Serag HB
通讯作者: El-Serag HB
DOI: 10.1002/hep.30664
发表时间: 2019-12-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Sanyal, Arun J.;Harrison, Stephen A.;Goodman, Zachary
通讯作者: Goodman, Zachary